These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2494725)

  • 1. Monte Carlo treatment planning and high-resolution alpha-track autoradiography for neutron capture therapy.
    Zamenhof RG; Clement S; Lin K; Lui C; Ziegelmiller D; Harling OK
    Strahlenther Onkol; 1989; 165(2-3):188-92. PubMed ID: 2494725
    [No Abstract]   [Full Text] [Related]  

  • 2. Analytical modeling for neutron capture therapy.
    Wheeler FJ; Griebenow ML; Wessol DE; Nigg DW
    Strahlenther Onkol; 1989; 165(2-3):186-8. PubMed ID: 2494724
    [No Abstract]   [Full Text] [Related]  

  • 3. A Monte Carlo investigation of the dosimetric properties of monoenergetic neutron beams for neutron capture therapy.
    Yanch JC; Zhou XL; Brownell GL
    Radiat Res; 1991 Apr; 126(1):1-20. PubMed ID: 2020734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interpretation of dose calculations and cell-survival measurements for the boron neutron capture therapy of brain tumours with 24 keV neurons.
    Mill AJ; Harrison KG
    Br J Radiol; 1988 Dec; 61(732):1147-54. PubMed ID: 3219496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose bracketing in boron neutron capture therapy.
    Gahbauer R; Kanellitsas C; Blue T; Wang C; Clendenon N; Fairchild R; Laster B; McGregor J; Goodman J
    Strahlenther Onkol; 1989; 165(2-3):229-30. PubMed ID: 2494738
    [No Abstract]   [Full Text] [Related]  

  • 6. Method of in situ dosimetry in boron neutron capture therapy.
    Blue J; Roberts W; Blue T; Wang C
    Strahlenther Onkol; 1989; 165(2-3):109-12. PubMed ID: 2494710
    [No Abstract]   [Full Text] [Related]  

  • 7. GE PETtrace cyclotron as a neutron source for boron neutron capture therapy.
    Bosko A; Zhilchenkov D; Reece WD
    Appl Radiat Isot; 2004 Nov; 61(5):1057-62. PubMed ID: 15308192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced survival in a rat glioma model following BNCT.
    Clendenon NR; Barth RF; Goodman JH; Staubus AE; Gordon WA; Moeschberger ML; Alam F; Soloway AH; Fairchild RG; Slatkin DN
    Strahlenther Onkol; 1989; 165(2-3):222-5. PubMed ID: 2494736
    [No Abstract]   [Full Text] [Related]  

  • 9. Head phantom experiment and calculation for NCT using various neutron beams.
    Matsumoto T; Aizawa O
    Strahlenther Onkol; 1989; 165(2-3):98-100. PubMed ID: 2494756
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy.
    Mill AJ
    Strahlenther Onkol; 1989; 165(2-3):193-6. PubMed ID: 2494726
    [No Abstract]   [Full Text] [Related]  

  • 11. Three cases of terminal stage malignant gliomas in which the diffusely disseminated intraventricular tumors became the target of boron neutron capture therapy.
    Montagno Ede A; Moreira Filho L; Hatanaka H
    Strahlenther Onkol; 1989; 165(2-3):238-40. PubMed ID: 2494740
    [No Abstract]   [Full Text] [Related]  

  • 12. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system.
    Lehmann J; Hartmann Siantar C; Wessol DE; Wemple CA; Nigg D; Cogliati J; Daly T; Descalle MA; Flickinger T; Pletcher D; Denardo G
    Phys Med Biol; 2005 Mar; 50(5):947-58. PubMed ID: 15798267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionation and other clinical considerations in boron neutron capture therapy.
    Durrant KR; Hopewell JW
    Strahlenther Onkol; 1989; 165(2-3):231-3. PubMed ID: 2494739
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated approach in the planning of neutron capture therapy.
    Ryabukhin YS
    Strahlenther Onkol; 1989; 165(2-3):158-62. PubMed ID: 2494721
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of gadolinium-157 as a neutron capture therapy agent.
    Brugger RM; Shih JA
    Strahlenther Onkol; 1989; 165(2-3):153-6. PubMed ID: 2494719
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives of the clinical BNCT of malignant gliomas in Czechoslovakia.
    Sourek K; Tovarys F
    Strahlenther Onkol; 1989; 165(2-3):247-9. PubMed ID: 2494741
    [No Abstract]   [Full Text] [Related]  

  • 17. Monte Carlo modelling of the influence of boron microdistribution on BNCT microdosimetry.
    Hugtenburg RP; Baker AE; Green S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S168-70. PubMed ID: 19394241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ionizing radiation and dexamethasone on the blood-brain-barrier and blood-tumor-barrier: implications for boron neutron capture therapy of brain tumors.
    Dorn RV; Spickard JH; Griebenow ML
    Strahlenther Onkol; 1989; 165(2-3):219-21. PubMed ID: 2494735
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimization of fast neutron spectra available for neutron capture therapy.
    Pfister G; Hehn G; el-Husseini F
    Strahlenther Onkol; 1989; 165(2-3):107-9. PubMed ID: 2494709
    [No Abstract]   [Full Text] [Related]  

  • 20. Calculation of dose components in head phantom for boron neutron capture therapy.
    da Silva AX; Crispim VR
    Cell Mol Biol (Noisy-le-grand); 2002 Nov; 48(7):813-7. PubMed ID: 12622057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.